Company
Myomo
Myomo is a medical robotics company developing powered upper-limb orthoses and exoskeletons for stroke and neurological rehabilitation, including the MyoPro…
- Founded
- 2004
- HQ
- Boston, Massachusetts, USA
- Status
- public (NYSE American: MYO)
Models
1
Deploy Watch
Track Myomo on Deploy.
We notify you when a verified state change lands on the record, not when the company issues a claim.
Key facts
Robot
MyoPro is a myoelectric (EMG-controlled) powered arm brace for people with arm/hand paralysis.
Focus
Powered upper-limb orthotics for paralysis patients.
Origin
MIT spinout.
Founded
2004
CEO
Paul Gudonis
Product
MyoPro 2+ powered upper-limb orthosis
Listed on
NYSE American: MYO
Application
Upper-limb paralysis, stroke rehabilitation
Data & sources
Web sources
2
2 sources backing this record.View all →
Models (1)
View all models →Current leadership (1)
- Paul Gudonis CEOreported, not verified
Safety record
No incidents on record for Myomo.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Recent coverage
Myomo in third-party press
Peer companies
- Honda3 models
- Ekso Bionics2 models
- German Bionic2 models
- Lifeward2 models
- ATOUN1 model
- B-TEMIA1 model
Financial state
- Reporting basis
- aggregator_estimate
- Lifecycle stage
- mature
- Counterparty risk class
- low
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Sources (2)
Common questions
- What is Myomo?
- Myomo is a medical robotics company developing powered upper-limb orthoses and exoskeletons for stroke and neurological rehabilitation, including the MyoPro myoelectric arm. (NYSE: MYO)
- What does Myomo make?
- Myomo has 1 robot model on the DEPLOY registry: Myomo MyoPro (Myomo builds physical robots).
- Is Myomo publicly traded?
- Yes. Myomo is publicly traded on public markets, per the DEPLOY registry.
- Who competes with Myomo?
- On the DEPLOY registry, peer companies to Myomo building in the same form factors include Honda, Ekso Bionics, German Bionic, Lifeward.
- Where is Myomo headquartered?
- Myomo is headquartered in Boston, Massachusetts, USA.
- Where does Myomo operate robots?
- Myomo is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.
- Is Myomo a top robotics company?
- On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Myomo ranks in roughly the top 74% of companies tracked by the registry.
- When was Myomo founded?
- Myomo was founded in 2004.
- Is Myomo safe?
- Myomo has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 2 sources (no primary) · last reviewed 2026-07-07
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-07-07
Sources by quality tier
- 2
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Myomo.Peer companies
- Honda3 models
- Ekso Bionics2 models
- German Bionic2 models
- Lifeward2 models
- ATOUN1 model
- B-TEMIA1 model
In the press
Recent coverage mentioning Myomo from third-party publications. Automatically surfaced; not part of the verified registry record.
MYO: Proprietary wearable robotics address a vast unmet need, driving growth toward $100M+ revenue - TradingView
<a…
Myomo Announces Participation in Upcoming Investor Conferences - Business Wire
<a…
Myomo Appoints William J Febbo to its Board of Directors - Business Wire
<a…
Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - Business Wire
<a…
5 High-Risk, High-Reward Microcap Stocks With Massive Upside Potential and Limited Analyst Coverage - TIKR.com
<a…
Myomo launches MyoPro 2x, enhancing independence for patients with arm and hand paralysis - Medical Economics
<a…
3 Underrated Robotics Stocks Poised for Major Growth - MarketBeat
<a…
ReWalk Robotics, Myomo to benefit from new proposed Medicare classifications - MassDevice
<a…
Myomo prices $6.5M public offering - MassDevice
<a…
Medicare provider certification granted to wearable robotics firm Myomo - The Robot Report
<a…
Myomo scales up production, training for MyoPro device for upper-body mobility - The Robot Report
<a…
Medical Robotics Is Myomo CEO Paul Gudonis’ Next Chapter - Chief Executive
<a…
Machine-readable surfaces
- Markdown mirror: /companies/myomo.md
- RSS feed: /companies/myomo/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/f9dacda5-f2c0-423e-9cff-1d31515bfb25
- Revision history: /companies/myomo/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Honda3 models
- Ekso Bionics2 models
- German Bionic2 models
- Lifeward2 models
- ATOUN1 model
- B-TEMIA1 model
Reality vs attention
Myomo draws attention at the 24th percentile but verifies reality at the insufficient-data level among exoskeletons.
Analysis
Limited public visibility and press coverage relative to peers.
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Jul 14, 2026